Immune activation caused by vascular oxidation promotes fibrosis and hypertension
Jing Wu(Nanjing Medical University), David G. Harrison(Vanderbilt University Medical Center), Kenneth E. Bernstein(Cedars-Sinai Medical Center), Jörg J. Goronzy(Mayo Clinic), Hua Cai(University of California, Los Angeles), John A. Curci(Vanderbilt University Medical Center), Meena S. Madhur(Indiana University School of Medicine), Raymond L. Mernaugh(Vanderbilt University), Hana A. Itani(Regeneron (United States)), Mohamed A. Saleh(Mansoura University), Heitor Moreno(Universidade Estadual de Campinas (UNICAMP)), Sean S. Davies(Vanderbilt University), Cornelia M. Weyand(Mayo Clinic), Liang Xiao(Tianjin Medical University), Annet Kirabo(Vanderbilt University), Wei Chen(Vanderbilt University), Kim Ramil C. Montaniel(Vanderbilt University Medical Center), L. Jackson Roberts(The University of Melbourne), Natália R. Barbaro(Universidade Estadual de Campinas (UNICAMP))
Cited by 231
Related Papers
Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.
|Journal of Clinical Investigation|1996|2.4k
Increase in Circulating Products of Lipid Peroxidation (F<sub>2</sub>-Isoprostanes) in Smokers — Smoking as a Cause of Oxidative Damage
|New England Journal of Medicine|1995|1.3k
Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus
|Circulation Research|2001|1.2k
Cellular and molecular mechanisms of endothelial cell dysfunction.
|Journal of Clinical Investigation|1997|1.1k